Fibromyalgia syndrome (FMS) is a medical condition characterized by chronic widespread pain and a heightened pain response to pressure. It has been thought of by conventional medicine as an invalid “catch all” term for conditions clinicians cannot determine. As such, little funding has been given to FMS for research. A core group of scientists from around the world have, however, been performing research with little or no funding.
A paper published this year in the journal Neuroscience by researchers in the U.K. and Sweden has given, for perhaps the first time, evidence that FMS is an autoimmune condition. In this paper, researchers took immunoglobulins from people with FMS and injected them into healthy mice. The mice then began to exhibit the same symptoms as the subjects with FMS.
While a treatment therapy is a way off, understanding the mechanisms of FMS is a first step in long series of steps to make this realized.